These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22592023)

  • 1. Melatonin and cardioprotection in the acute myocardial infarction: a promising cardioprotective agent.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Reiter RJ
    Int J Cardiol; 2012 Jul; 158(2):309-10. PubMed ID: 22592023
    [No Abstract]   [Full Text] [Related]  

  • 2. Short- and long-term effects of melatonin on myocardial post-ischemic recovery.
    Lochner A; Genade S; Davids A; Ytrehus K; Moolman JA
    J Pineal Res; 2006 Jan; 40(1):56-63. PubMed ID: 16313499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGF165 gene-mediated arteriogenesis and cardioprotection in large mammals with acute myocardial infarction. Confirmation of previous results from other authors.
    Crottogini A; Laguens R
    Circ Res; 2007 Mar; 100(4):e58. PubMed ID: 17332432
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation.
    Patel V; Upaganlawar A; Zalawadia R; Balaraman R
    Eur J Pharmacol; 2010 Oct; 644(1-3):160-8. PubMed ID: 20624385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has melatonin a future as a cardioprotective agent?
    Duncker DJ; Verdouw PD
    Cardiovasc Drugs Ther; 2001; 15(3):205-7. PubMed ID: 11713886
    [No Abstract]   [Full Text] [Related]  

  • 6. The protective effect of melatonin on adriamycin-induced acute cardiac injury.
    Koçak G; Erbil KM; Ozdemir I; Aydemir S; Sunar B; Tuncel M; Atalay S
    Can J Cardiol; 2003 Apr; 19(5):535-41. PubMed ID: 12717489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection with melatonin in the acute myocardial infarction: awaiting results of MARIA trial?
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Saiz Mdel M; Aldea-Perona A; de la Torre JM; Garcia-Camarero T; Consuegra-Sanchez L;
    Int J Cardiol; 2015 Mar; 182():54-5. PubMed ID: 25590959
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials.
    Gerczuk PZ; Kloner RA
    J Am Coll Cardiol; 2012 Mar; 59(11):969-78. PubMed ID: 22402067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection.
    Kloner RA; Nesto RW
    Circulation; 2008 May; 117(19):2523-33. PubMed ID: 18474824
    [No Abstract]   [Full Text] [Related]  

  • 10. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia M; Ferrer J; de la Rosa A; Vargas M; Reiter RJ
    Cytokine; 2004 Apr; 26(2):89-93. PubMed ID: 15050609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol as a cardioprotective agent.
    Frishman WH
    Heart Dis; 2002; 4(5):273-5. PubMed ID: 12350237
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats.
    Peer PA; Trivedi PC; Nigade PB; Ghaisas MM; Deshpande AD
    Int J Cardiol; 2008 May; 126(1):123-6. PubMed ID: 17467089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pharmacological preconditioning against ischemia.
    Luca MC; Liuni A; Muxel S; Münzel T; Forconi S; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2011; 49(1-4):287-93. PubMed ID: 22214700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin: Still a forgotten antioxidant.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Int J Cardiol; 2011 Jun; 149(3):382. PubMed ID: 21414673
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effects of melatonin in cardiovascular disease.
    Reiter RJ; Tan DX; Paredes SD; Fuentes-Broto L
    Ann Med; 2010 May; 42(4):276-85. PubMed ID: 20455793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAY 58-2667, a nitric oxide-independent guanylyl cyclase activator, pharmacologically post-conditions rabbit and rat hearts.
    Krieg T; Liu Y; Rütz T; Methner C; Yang XM; Dost T; Felix SB; Stasch JP; Cohen MV; Downey JM
    Eur Heart J; 2009 Jul; 30(13):1607-13. PubMed ID: 19406872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin and myocardial protection.
    Lavi R; Lavi S
    Int J Cardiol; 2011 Jul; 150(2):207. PubMed ID: 21592602
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats.
    Ali MS; Mudagal MP; Goli D
    Pharmazie; 2009 Feb; 64(2):132-6. PubMed ID: 19320287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of amiodarone during acute period in isoproterenol-induced myocardial injury in Wistar rats.
    Albayrak F; Bayir Y; Halici Z; Kabalar E; Bayram E; Ozturk C; Suleyman H; Keles MS; Kurt M; Bakan E
    Cardiovasc Toxicol; 2009 Dec; 9(4):161-8. PubMed ID: 19714493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.